Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Bravo Montenegro

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Surgical Oncology|February 17, 2021
Immunotherapy in lung cancerGabriela Bravo Montenegro, Saira Farid, Stephen V Liu
Current Opinion in Oncology|March 29, 2025
Biomarkers in advanced renal cell carcinoma: current practice and future directionsVivian Wong, Taylor Goodstein, Gabriela Bravo Montenegro, et al.
Current Opinion in Oncology|March 24, 2026
Unclear territory: navigating metastatic nonclear cell renal cell carcinomaTaylor Goodstein, Vivian Wong, Gabriela Bravo Montenegro, et al.
Urologic Oncology|September 11, 2025
Metastasectomy outcomes in renal cell carcinoma: insights from hereditary leiomyomatosis and succinate dehydrogenase deficient cohortsMilan H Patel, Ruben Blachman-Braun, Braden Millan, et al.
JTO Clinical and Research Reports|November 14, 2025
Characteristics of Short-Term Survivors With <i>ALK</i> or <i>ROS1</i>-Altered Metastatic NSCLCKai-Lin Liu, Alex Watts, Connor B Grady, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Surgical Oncology|February 17, 2021
Immunotherapy in lung cancerGabriela Bravo Montenegro, Saira Farid, Stephen V Liu
Current Opinion in Oncology|March 29, 2025
Biomarkers in advanced renal cell carcinoma: current practice and future directionsVivian Wong, Taylor Goodstein, Gabriela Bravo Montenegro, et al.
Current Opinion in Oncology|March 24, 2026
Unclear territory: navigating metastatic nonclear cell renal cell carcinomaTaylor Goodstein, Vivian Wong, Gabriela Bravo Montenegro, et al.
Urologic Oncology|September 11, 2025
Metastasectomy outcomes in renal cell carcinoma: insights from hereditary leiomyomatosis and succinate dehydrogenase deficient cohortsMilan H Patel, Ruben Blachman-Braun, Braden Millan, et al.
JTO Clinical and Research Reports|November 14, 2025
Characteristics of Short-Term Survivors With <i>ALK</i> or <i>ROS1</i>-Altered Metastatic NSCLCKai-Lin Liu, Alex Watts, Connor B Grady, et al.
Pageof 1